POLYRADICULITIS CRANIALIS ODER DAS SOGENANNTE FISHER-SYNDROM. = POLYRADICULITE DU TYPE FISHER SYNDROMEKETZ E; HOLDENER E.1976; SCHWEIZ. MED. WSCHR.; SCHWEIZ; DA. 1976; VOL. 106; NO 51; PP. 1862-1866; BIBL. 13 REF.Article

DER ⁵⁷CO-EXKRETIONS- UND RESORPTIONSTEST IN DER DIAGNOSE DER EISENMANGELANAEMIE. = LE TEST D'EXCRETION ET DE RESORPTION DE CO57 DANS LE DIAGNOSTIC DE L'ANEMIE PAR CARENCE EN FERBEKIER A; HOLDENER E.1977; NUKLEARMEDIZIN; DTSCH.; DA. 1977; VOL. 15; NO 3; PP. 126-130; ABS. ANGL.; BIBL. 19 REF.Article

Retinoids in cancer prevention and therapyBOLLAG, W; HOLDENER, E. E.Annals of oncology. 1992, Vol 3, Num 7, pp 513-526, issn 0923-7534Article

THERAPEUTISCHE ERFAHRUNGEN MIT DEM NEUEN PODOPHYLLOTOXINDERIVAT VP 16-213 BEI MENSCHLICHEN MALIGNEN TUMOREN. = RESULTATS THERAPEUTIQUES DU TRAITEMENT DE TUMEURS MALIGNES HUMAINES PAR UN DERIVE DE LA PODOPHYLLOTOXINE, LE VP 16-213JUNGI WF; SENN HJ; BECKMANN C et al.1975; SCHWEIZ. MED. WSCHR.; SCHWEIZ; DA. 1975; VOL. 105; NO 42; PP. 1365-1369; ABS. ANGL.; BIBL. 15 REF.Article

Inhibited methionine incorporation in human squamous carcinomas of the oral cavity as a measure for response to 5-fluorouracilGOROGH, T; EICKBOHM, J. E; EWERS, R et al.Journal of cancer research and clinical oncology. 1989, Vol 115, Num 4, pp 366-372, issn 0171-5216, 7 p.Article

Recombinant interferon α-2A combined with prednisone in metastatic renal-cell carcinoma : treatment results, serum interferon levels and the development of antibodiesFOSSA, S. D; LEHNE, G; GUNDERSON, R et al.International journal of cancer. 1992, Vol 50, Num 6, pp 868-870, issn 0020-7136Article

Phase I study of oral doxifluridine using two schedulesAL BERTO, P; WINKELMANN, J. J; PASCHOUD, N et al.European journal of cancer & clinical oncology. 1989, Vol 25, Num 5, pp 905-908, issn 0277-5379Article

Treatment of thrombocytosis in myeloproliferative disorders with interferon alpha-2aTICHELLI, A; GRATWOHL, A; BERGER, C et al.Blut. 1989, Vol 58, Num 1, pp 15-19, issn 0006-5242Article

Interferon-alpha and survival in renal cell cancerFOSSA, S; JONES, M; JOHNSON, P et al.British journal of urology (Print). 1995, Vol 76, Num 3, pp 286-290, issn 0007-1331Article

Phase II study of amsacrine in refractory lymphomas: a report of the EORTC early clinical trials group = Etude phase II de l'Amsa dans les lymphomes réfractaires. Essai de l'EORTCBRAMWELL, V. H. C; HOLDENER, E. E; SIEGENTHALER, P et al.European journal of cancer & clinical oncology. 1984, Vol 20, Num 6, pp 753-759, issn 0277-5379Article

Phase II trial of menogaril in advanced colorectal cancerHOLDENER, E. E; TEN BOKKEL HUININK, W. W; DECOSTER, G et al.Investigational new drugs. 1988, Vol 6, Num 3, pp 227-230, issn 0167-6997Article

Phase II trial of diaziquone in advanced renal adenocarcinoma = Essai phase II de la diaziquone dans les tumeurs avancées du reinHANSEN, M; GALLMEIER, W. M; VERMORKEN, J et al.Cancer treatment reports. 1984, Vol 68, Num 7-8, pp 1055-1056, issn 0361-5960Article

13-cis-retinoic acid plues interferon-α2a in locally advanced squamous cell carcinoma of the cervixLIPPMAN, S. M; KAVANAGH, J. J; PAREDES-ESPINOZA, M et al.Journal of the National Cancer Institute. 1993, Vol 85, Num 6, pp 499-500, issn 0027-8874Article

Phase II trial of anaxirone (TGU) in advanced colorectal cancer : an EORTC early clinical trials group (ECTG) studyHOLDENER, E. E; CLAVEL, M; SESSA, C et al.European journal of cancer. Part A. 1994, Vol 30, Num 3, pp 394-395Article

Primary hypothyroidism associated with interleukin-2 and interferon alpha-2 therapy of melanoma and renal carcinomaSCALZO, S; GENGARO, A; TESTA, U et al.European journal of cancer (1990). 1990, Vol 26, Num 11-12, pp 1152-1156, issn 0959-8049Article

Combination chemotherapy for non-small cell lung cancer with doxorubicin and mitomycin or cisplatin and etoposideJOSS, R. A; ALBERTO, P; OBRECHT, J. P et al.Cancer treatment reports. 1984, Vol 68, Num 9, pp 1079-1084, issn 0361-5960Article

Combination chemotherapy with mitomycin, vindesine, and cisplatin for non-small cell lung cancerJOSS, R. A; BUÊRKI, K; HOLDENER, E. E et al.Cancer. 1990, Vol 65, Num 11, pp 2426-2434, issn 0008-543X, 9 p.Article

Recombinant interferon alfa-2a with or without vinblastine in metastatic renal cell carcinoma : results of a European multi-center phase III studyFOSSA, S. D; MARTINELLI, G; OTTO, U et al.Annals of oncology. 1992, Vol 3, Num 4, pp 301-305, issn 0923-7534Article

Retinoic acid and interferon combination studies in human cancerLIPPMAN, S. M; GLISSON, B. S; KAVANAGH, J. J et al.European journal of cancer. Part A. 1993, Vol 29, pp S9-S13, SUP5Conference Paper

13-cis-retinoic acid plus interferon α-2a : highly active systemic therapy for squamous cell carcinoma of the cervixLIPPMAN, S. M; KAVANAGH, J. J; PAREDES-ESPINOZA, M et al.Journal of the National Cancer Institute. 1992, Vol 84, Num 4, pp 241-245, issn 0027-8874Article

Clinical experience with the combined use of recombinant interleukin-2 (IL2) and interferon alfa-2a (IFNα) in metastalic melanomaKRUIT, W. H. J; GOEY, S. H; STOTER, G et al.British journal of haematology. 1991, Vol 79, pp 84-86, issn 0007-1048, SUP1Conference Paper